Your browser doesn't support javascript.
loading
Can Smartphone Notifications Help With Gout Management? A Feasibility Study.
Emad, Yasaman; Dalbeth, Nicola; Weinman, John; Chalder, Trudie; Petrie, Keith J.
Afiliação
  • Emad Y; Y. Emad, MA, K.J. Petrie, PhD, Department of Psychological Medicine, University of Auckland, Auckland, New Zealand; y.emad@auckland.ac.nz.
  • Dalbeth N; N. Dalbeth, MD, Department of Medicine, University of Auckland, Auckland, New Zealand.
  • Weinman J; J. Weinman, PhD, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
  • Chalder T; T. Chalder, PhD, School of Psychology, King's College London, London, UK.
  • Petrie KJ; Y. Emad, MA, K.J. Petrie, PhD, Department of Psychological Medicine, University of Auckland, Auckland, New Zealand.
J Rheumatol ; 51(2): 189-196, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-37967906
ABSTRACT

OBJECTIVE:

This feasibility study aimed to assess the acceptability of using smartphone notifications to modify the medication beliefs of people with gout. We evaluated the feasibility and acceptability of a smartphone application using the Technology Acceptance Model. We explored adherence rate differences and outcomes between the intervention and control groups.

METHODS:

Fifty-two patients with gout who were prescribed allopurinol were randomly assigned to either active control (n = 24) or intervention group (n = 28). Over 3 months, both groups used the study app on their smartphones. The active control group received notifications about general health advice, whereas the intervention group received adherence-targeted notifications. The feasibility and acceptability of the smartphone app was measured through semistructured interviews. Adherence rate was assessed through serum urate levels and missed doses at 3 timepoints baseline, 3 months (post intervention), and 6 months (follow-up).

RESULTS:

The smartphone app demonstrated high feasibility, with strong participant retention and compliance. The participants expressed high levels of satisfaction with the app's user-friendliness and content, highlighting its acceptability. Both groups showed a significant reduction in missed doses over time (P < 0.05), but no significant differences in serum urate levels were found between the groups. Patients who received adherence-targeted notifications reported finding it more convenient to take allopurinol and expressed higher overall treatment satisfaction throughout the study.

CONCLUSION:

Adherence-targeted notifications have the potential to be an effective and scalable approach to supporting medication adherence in patients with gout. Further research is needed with larger samples to refine the components of the intervention and explore its optimal implementation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aplicativos Móveis / Gota Limite: Humans Idioma: En Revista: J Rheumatol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aplicativos Móveis / Gota Limite: Humans Idioma: En Revista: J Rheumatol Ano de publicação: 2024 Tipo de documento: Article